Background: FK506-binding protein 9 (FKBP9) is amplified in high-grade gliomas (HGGs). However, the roles and mechanism(s) of FKBP9 in glioma are unknown.

Methods: The expression of FKBP9 in clinical glioma tissues was detected by immunohistochemistry (IHC). The correlation between FKBP9 expression levels and the clinical prognosis of glioma patients was examined by bioinformatic analysis. Glioblastoma (GBM) cell lines stably depleted of FKBP9 were established using lentiviruses expressing shRNAs against FKBP9. The effects of FKBP9 on GBM cells were determined by cell-based analyses, including anchorage-independent growth, spheroid formation, transwell invasion assay, confocal microscopy, immunoblot (IB) and coimmunoprecipitation assays. In vivo tumor growth was determined in both chick chorioallantoic membrane (CAM) and mouse xenograft models.

Results: High FKBP9 expression correlated with poor prognosis in glioma patients. Knockdown of FKBP9 markedly suppressed the malignant phenotype of GBM cells in vitro and inhibited tumor growth in vivo. Mechanistically, FKBP9 expression induced the activation of p38MAPK signaling via ASK1. Furthermore, ASK1-p38 signaling contributed to the FKBP9-mediated effects on GBM cell clonogenic growth. In addition, depletion of FKBP9 activated the IRE1α-XBP1 pathway, which played a role in the FKBP9-mediated oncogenic effects. Importantly, FKBP9 expression conferred GBM cell resistance to endoplasmic reticulum (ER) stress inducers that caused FKBP9 ubiquitination and degradation.

Conclusions: Our findings suggest an oncogenic role for FKBP9 in GBM and reveal FKBP9 as a novel mediator in the IRE1α-XBP1 pathway.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7048151PMC
http://dx.doi.org/10.1186/s13046-020-1541-0DOI Listing

Publication Analysis

Top Keywords

fkbp9
16
fkbp9 expression
16
gbm cell
12
resistance endoplasmic
8
endoplasmic reticulum
8
reticulum stress
8
stress inducers
8
prognosis glioma
8
glioma patients
8
fkbp9 gbm
8

Similar Publications

Low-grade gliomas are divided into two main genetic phenotypes based on the presence or absence of mutations in the isocitrate dehydrogenase () genes. The mutated IDH phenotype (IDHmut), in contrast to the wild-type phenotype (IDHwt), is characterized by a more positive response to pharmacological intervention and a significantly longer survival time. In this study, we analyzed the differential co-expression of 225,000 microRNA-mRNA pairs at the level of correlations between microRNA levels and their potential mRNA targets.

View Article and Find Full Text PDF

The stability of FKBP9 maintained by BiP is crucial for glioma progression.

Genes Dis

November 2024

Division of Abdominal Tumor Multimodality Treatment and Laboratory of Animal Tumor Models, Cancer Center and State Key Laboratory of Respiratory Health and Multimorbidity and Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.

Article Synopsis
  • FK506-binding protein 9 (FKBP9) contributes to tumor malignancy by helping cancer cells resist endoplasmic reticulum (ER) stress, and higher levels of FKBP9 are linked to poorer patient outcomes.
  • The study identified BiP as a key binding partner of FKBP9, which stabilizes FKBP9 and correlates positively with poor prognosis in glioma patients.
  • Knocking out FKBP9 in engineered mice reduced glioblastoma formation and increased survival, indicating that the BiP-FKBP9 signaling pathway could be a promising target for glioma therapy.
View Article and Find Full Text PDF

Machine learning-based autophagy-related prognostic signature for personalized risk stratification and therapeutic approaches in bladder cancer.

Int Immunopharmacol

September 2024

Department of Urology, Urology Research Institute, the First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China; Department of Urology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou 350212, China; Fujian Key Laboratory of Precision Medicine for Cancer, the First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China. Electronic address:

Article Synopsis
  • Bladder cancer (BCa) is a severe and diverse type of cancer, with autophagy emerging as a critical biomarker for diagnosing and predicting outcomes in various cancers, but specific tools for BCa are limited.
  • A new autophagy-related prognostic signature (ARPS) was created using advanced machine learning techniques, showing it can better predict BCa prognosis and treatment responses than existing clinical markers.
  • The research identified four new drug targets and confirmed that the gene FKBP9 contributes to BCa cell growth and spread, providing new insights for patient management and therapy decisions.
View Article and Find Full Text PDF

Background: Renal cell carcinoma is the most common form of kidney cancer which is a global threat to human health, needing to explore effective therapeutic targets and treatment methods. Aurora kinase B acts as an important carcinogenic role in various kinds of tumors, while its mechanism in renal cell carcinoma is indistinct. Herein we explore the underlying mechanism of Aurora kinase B in renal cell carcinoma.

View Article and Find Full Text PDF
Article Synopsis
  • * Researchers found that miR-3074-3p inhibits hDPSCs' ability to differentiate into odontoblasts, but using antagomiR-3074-3p-conjugated PEI-AuNPs can promote this differentiation in lab settings.
  • * In vivo experiments on rats showed that these antagomiR-3074-3p nanoparticles enhanced the formation of restorative dentin, suggesting a potential new approach for dental repair and regeneration.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!